The role of cerebral ischemia in Alzheimer's disease

Neurobiology of Aging

Volumn 21, Issue 2, 2000, Pages 321-330

  Kalaria, Raj N ^a,b  

^a Inst Hlth Elderly   (United Kingdom)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

Alzheimer's disease; Cerebral ischemia; Cerebrovascular disease; Cognitive impairment; Stroke; Vascular disease

Indexed keywords

AMYLOID;

AGE; AGING; ALZHEIMER DISEASE; ATHEROSCLEROSIS; AUTOPSY; BRAIN ATHEROSCLEROSIS; BRAIN ISCHEMIA; CEREBROVASCULAR DISEASE; COGNITIVE DEFECT; CONFERENCE PAPER; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE COURSE; ENDOTHELIUM; HEART ATRIUM FIBRILLATION; HEREDITY; HUMAN; HYPERTENSION; NEUROPATHOLOGY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RISK FACTOR; STROKE; VASCULAR DISEASE; WHITE MATTER;

ALZHEIMER DISEASE; BRAIN ISCHEMIA; CEREBROVASCULAR CIRCULATION; HUMANS; RISK FACTORS;

EID: 0034603512     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-4580(00)00125-1     Document Type: Conference Paper

References (90)

1. Abe K., Tanzi R.E., Kogure K. Selective induction of Kunitz-type protease inhibitor domain-containing amyloid precursor protein mRNA after persistent focal ischemia in rat cerebral cortex. Neurosci Lett. 125:1991;172-174.
2. Aharon-Peretz J., Harel T., Revach M., Ben-Haim S.A. Increased sympathetic and decreased parasympathetic cardiac innervation in patients with Alzheimer's disease. Arch Neurol. 49:1992;919-922.
3. Alzheimer A. Uber eine eigenartig Erkrankung der Hirnrinde. Allg Z Psychiatrie Psych Ger Med. 64:1907;146-148.
4. Amouyel P., Richard F., Cottel D., Amant C., Codron V., Helbecque N. The deletion allele of the angiotensin I converting enzyme gene as a genetic susceptibility factor for cognitive impairment. Neurosci Lett. 217:1996;203-205.
5. Ballard C., McKeith I., O'Brien J., Kalaria R.N., et al. Neuropathological substrates of dementia and depression in vascular dementia, with particular focus on cases with small infarct volumes. Dementia. 11:2000;59-65.
6. Baum L., Chen L., Masliah E., Chan Y.S., Ng H.K., Pang C.P. Lipoprotein lipase mutations and Alzheimer's disease. Am J Med Genet. 88:1999;136-139.
7. Blennow K., Wallin A., Agren H., Spenger C., Siegfried J., Vanmechelen E. Tau protein in cerebrospinal fluid a biochemical marker for axonal degeneration in Alzheimer disease? Mol Chem Neuropathol. 26:1995;231-245.
8. Bronge L., Fernaeus S.E., Blomberg M., et al. White matter lesions in Alzheimer patients are influenced by apolipoprotein E genotype. Dement Geriatr Cogn Disord. 10:1999;89-96.
9. Brun A. Pathology and pathophysiology of cerebrovascular dementia pure subgroups of obstructive and hypoperfusive etiology . Dementia. 5:1994;145-147.
10. Bullido M., Artiga M.J., Recuero M., et al. A polymorphism in the regulatory region of APOE associated with risk for Alzheimer's dementia. Nature Genetics. 18:1998;69-71.
11. Cambien F., Poirier O., Lecerf L., et al. Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature. 359:1992;641-644.
12. Campbell J.H., Campbell G.R. The cell biology of atherosclerosis-new developments. Aust NJ J Med. 27:1997;497-500.
13. Castellano M., Barlassina C., Muiesan M.L., et al. Alpha-adducin gene polymorphism and cardiovascular phenotypes in a general population. J Hypertens. 15:1997;1707-1710.
14. Clarke R., Smith A.D., Jobst K.A., Refsum H., Sutton L., Ueland P.M. Folate, vitamin B12, and serum total homocysteine levels in confirmed Alzheimer disease. Arch Neurol. 55:1998;1449-1455.
15. Cochran E., Bacci B., Chen Y., Patton A., Gambetti P., Autilio-Gambetti L. Amyloid precursor protein and ubiquitin immunoreactivity in dystrophic axons is not unique to Alzheimer's disease. Am J Pathol. 139:1991;485-489.
16. Davignon J., Gregg R.E., Sing C.F. Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis. 8:1988;1-21.
17. de la Torre J.C. Hemodynamic consequences of deformed microvessels in the brain in Alzheimer's disease. Ann NY Acad Sci. 826:1997;75-91.
18. Erkinjuntti T., Benavente O., Eliasziw M., Munoz D.G., Sulkava R., Haltia M., Hachinski V. Diffuse vaculolization (Spongiosis) and anteriosclerosis in the frontal white matter occurs in vascular dementia. Arch Neurol. 53:1996;325-332.
19. Esiri M.M., Wilcock G.K., Morris J.H. Neuropathological assessment of the lesions of significance in vascular dementia. J Neurol Neurosurg Psychiatry. 63:1997;749-753.
20. Esiri M.M., Nagy Z., Smith M.Z., Barneston L., Smith A.D. Cerebrovascular disease and threshold for dementia in the early stages of Alzheimer's disease. Lancet. 354:1999;919-920.
21. Ferrucci L., Guralnik J.M., Salive M.E., et al. Cognitive impairment and risk of stroke in the older population. J Am Geriatr Soc. 44:1996;237-241.
22. Frisoni G.B., Calabresi L., Geroldi C., et al. Apolipoprotein E ε4 allele in Alzheimer's disease and vascular dementia. Dementia. 5:1994;240-242.
23. Gale C.R., Martyn C.N., Cooper C. Cognitive impairment and mortality in a cohort of elderly people. Br Med J. 312:1996;608-611.
24. Graham D.I., Ford I., Adams J.H., et al. Ischaemic brain damage is still common in fatal non-missile head injury. J Neurol Neurosurg Psychiatry. 52:1989;346-350.
25. Griffin W.S., Sheng J.G., Gentleman S.M., Graham D.I., Mrak R.E., Roberts G.W. Microglial IL-1α expression in human head injury correlations with neuronal and neuritic β-amyloid precursor protein expression . Neurosci Lett. 176:1994;133-136.
26. Haviland M.B., Lussier-Cacan S., Davignon J., Sing C.F. Impact of apolipoprotein E genotype variation on means, variances and correlations of plasma lipid, lipoprotein, and apolipoprotein traits in octogenarians. Am J Med Genet. 58:1995;315-331.
27. Henon H., Pasquier F., Durieu I., et al. Pre-existing stroke in patients baseline frequency, associated factors and outcome . Stroke. 28:1997;2429-2436.
28. Heyman A., Fillenbaum G.G., Welsh-Bohmer K.A., et al. Cerebral infarcts in patients with autopsy-proven Alzheimer's disease. CERAD Part XVIII. Neurology. 51:1998;159-162.
29. Hofman A., Ott A., Breteler M.M.B., et al. Atherosclerosis, apolipoprotein E, and the prevalence of dementia and Alzheimer's disease in the Rotterdam Study. Lancet. 349:1997;151-154.
30. Iadecola C., Zhang F., Niwa K., et al. SOD1 rescues cerebral endothelial dysfunction in mice overexpressing amyloid precursor protein. Nat Neurosci. 2:1999;157-161.
31. Kalaria R.N. The blood-brain barrier and cerebral microcirculation in Alzheimer's disease. Cerebrovasc Brain Metab Rev. 4:1992;226-260.
32. Kalaria R.N. Cerebral vessels in ageing and Alzheimer's disease. Pharmacol Ther. 72:1996;193-214.
33. Kalaria R.N. Apolipoprotein E, arteriosclerosis, and Alzheimer's disease. Lancet. 349:1997;1174-1175.
34. Kalaria R.N., Hedera P. Differential degeneration of the endothelium and basement membrane of capillaries in Alzheimer's disease. Neuroreport. 6:1995;477-480.
35. Kalaria R.N., Bhatti S.U., Palatinsky E.A., et al. Accumulation of the β amyloid precursor protein at sites of ischemic injury in rat brain. Neuroreport. 4:1993;211-214.
36. Kalaria R.N., Bhatti S.U., Perry G., Lust W.D. The amyloid precursor protein in ischemic brain injury and chronic hypoperfusion. Ann N Y Acad Sci. 695:1993;190-193.
37. Kalaria R.N., Pax A.B., Premkumar D.R.D., Lieberburg I. Production and increased detection of amyloid β-protein and amyloidogenic fragments in brain microvessels, meningeal vessels and choroid plexus in Alzheimer disease. Mol Brain Res. 35:1996;58-68.
38. Kalaria R.N., Lewis H.D., Thomas N.J., Shearman M.S. Brain Aβ42 and Aβ40 concentrations in multi-infarct dementia and Alzheimer's disease. Soc Neurosci Abstr. 23:1999;1114.
39. Kalmijn S., Launer L.J., Ott A., Witteman J.C., Hofman A., Breteler M.M. Dietary fat intake and the risk of incident dementia in the Rotterdam Study. Ann Neurol. 42:1997;776-782.
40. Kamboh M.I., Aston C.E., Perez-Tur J., et al. A novel mutation in the apolipoprotein E gene (APOE*4 Pittsburgh) is associated with the risk of late-onset Alzheimer's disease. Neurosci Lett. 263:1999;129-132.
41. Kehoe P.G., Russ C., McLlory S., et al. Variation in DCP1, encoding ACE, is associated with susceptibility to Alzheimer's disease. Nat Genet. 21:1999;71-72.
42. Kessler C., Spitzer C., Stausk D., et al. The apolipoprotein E and β-fibrinogen G/A-455 gene ploymorphisms are associated with ischemic stroke involving large-vessel disease. Arterioscler Thromb Vasc Biol. 17:1997;2880-2884.
43. Kokmen E., Whisnant J.P., O'Fallon W.M., Chu C.P., Beard C.M. Dementia after ischaemic stroke a population based study in Rochester, Minnesota (1960-1984) . Neurology. 46:1996;154-159.
44. Kosunen O., Talasniemi S., Lehtovirta M., et al. Relation of coronary atherosclerosis and apolipoprotein E genotypes in Alzheimer patients. Stroke. 26:1995;743-748.
45. Kudo T., Imaizumi K., Tanimukai H., et al. Are cerebrovascular factors involve in Alzheimer's disease? Neurobiol Aging. 21:2000;215-224.
46. Kuo Y.M., Emmerling M.R., Bisgaier C.L., et al. Elevated low-density lipoprotein in Alzheimer's disease correlates with brain abeta 1-42 levels. Biochem Biophys Res Comm. 252:1998;711-715.
47. Lambert J.C., Berr C., Pasquier F., et al. Pronounced impact of Th1/E47cs mutation compared with 491 AT mutation on neural APOE gene expression and risk of developing Alzheimer's disease. Hum Mol Genet. 7:1998;1511-1516.
48. Leys D, Pasquier F, Scheletens P, editors. Stroke and Alzheimer's disease. Curr Issues in Neurodegenerative Dis 1998; vol 9. The Hague- The Netherlands: Holland Academic Graphics.
49. Mahley R.W. Apolipoprotein E cholesterol transport protein with expanding role in cell biology . Science. 240:1988;622-630.
50. Margaglione M., Seripa D., Gravina C., et al. Prevalence of apolipoprotein E alleles in healthy subjects and survivors of ischemic stroke an Italian case-control study . Stroke. 29:1998;399-403.
51. Montgomery H., Clarkson P., Barnard M., et al. Angiotensin-converting-enzyme gene insertion/deletion polymorphism and response to physical training. Lancet. 353:1999;541-545.
52. Munroe W.A., Southwick P.C., Chang L., et al. Tau protein in cerebrospinal fluid as an aid in the diagnosis of Alzheimer's disease. Ann Clin Lab Sci. 25:1995;207-217.
53. Nagy Zs, Esiri M.M., Joachim C., et al. Comparison of pathological diagnostic criteria for Alzheimer disease. Alzheimer Dis Assoc Disord. 12:1998;182-189.
54. Nakamura Y., Takeda M., Niigawa H., Hariguchi S., Nishimura T. Amyloid β-protein precursor deposition in rat hippocampus lesioned by ibotenic acid injection. Neurosci Lett. 136:1992;95-98.
55. Nicoll J.A.R., Roberts G.W., Graham D.I. Apolipoprotein E ε4 allele is associated with deposition of amyloid β-protein following head injury. Nature Med. 1:1995;135-137.
56. Nolan K.A., Lino M.M., Seligmann A.W., Blas J.P. Absence of vascular dementia in an autopsy series from a dementia clinic. J Am Geriatr Soc. 46:1998;597-604.
57. Notkola I.-L., Sulkava R., Pekkanen J., et al. Serum total cholesterol, apolipoprotein E e4 allele, and Alzheimer's disease. Neuroepidemiology. 17:1998;14-20.
58. Olichney J.M., Hansen L.A., Hofstetter C.R., Grundman M., Katzman R., Thal L.J. Cerebral infarction in Alzheimer's disease is associated with severe amyloid angiopathy and hypertension. Arch Neurol. 52:1995;702-708.
59. Olichney J.M., Hansen L.A., Hofstetter C.R., Grundman M., Katzman R., Thal L.J. Apolipoprotein epsilon 4 allele is associated with increased neuritic plaques and CAA in Alzheimer's disease and Lewy body variant. Neurology. 47:1996;190-196.
60. Otsuka N., Tomonaga M., Ikeda K. Rapid appearance of β-amyloid precursor protein immunoreactivity in damaged axons and reactive glial cells in rat brain following needle stab injury. Brain Res. 568:1991;335-338.
61. Ott A., Breteler M.M.B., de Bruyne M.C., van Harskamp F., Grobbee D.E., Hofman A. Atrial fibrillation and dementia in a population-based study. The Rotterdam Study. Stroke. 28:1997;316-321.
62. Ott A., Stolk R.P., van Harskamp F., Pols H.A., Hofman A., Breteler M.M. Diabetes mellitus and the risk of dementia the Rotterdam Study . Neurology. 53:1999;1937-1942.
63. Pasquier F., Leys D., Scheltens P. The influence of coincidental vascular pathology on symptomatology and course of Alzheimer's disease. J Neural Transm Suppl. 54:1998;117-127.
64. Premkumar D.R.D., Cohen D.L., Hedera P., Friedland R.P., Kalaria R.N. Apolipoprotein E e4 alleles in CAA and cerebrovascular pathology in Alzheimer's disease. Am J Pathol. 148:1996;2083-2095.
65. Raby C.A., Morganti-Kossmann M.C., Kossmann T., et al. Traumatic brain injury increases beta-amyloid peptide 1-42 in cerebrospinal fluid. J Neurochem. 71:1998;2505-2509.
66. Rigat B., Hubert C., Alhenc-Gelas F., Cambien F., Corvol P., Soubrier F. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half of the variance of serum enzyme levels. J Clin Invest. 86:1990;1343-1346.
67. Roberts G.W., Gentleman S.M., Lynch A., Graham D.I. βA4 amyloid protein deposition in brain after head trauma. Lancet. 338:1991;1422-1423.
68. Roberts G.W., Gentleman S.M., Lynch A., Murray L., Landon M., Graham D.I. β amyloid protein deposition in brain after severe head injury implications for the pathogenesis of Alzheimer's disease . J Neurol Neurosurg Psychiatry. 57:1994;419-425.
69. Sagnella G.A., Rothwell M.J., Onipinla Ak, Wicks P.D., Cook D.G., Cappuccio F.P. A population study of ethnic variations in the angiotensin-converting enzyme I/D polymorphism relationships with gender, hypertension and impaired glucose metabolism . J Hypertens. 17:1999;657-664.
70. Saido T.C., Yokota M., Maruyama K., et al. Saptial resolution of the primary β-amyloidogenic process induced in postischemic hippocampus. J Biol Chem. 269:1994;15253-15257.
71. Schmidt H., Schmidt R., Niederkorn K., et al. Beta-fibrinogen gene polymorphism (C148→T) is associated with carotid atherosclerosis results of the Austrian stroke prevention study . Arterioscler Thromb Vasc Biol. 18:1998;487-492.
72. Siman R., Card J.P., Nelson R.B., Davis L.G. Expression of β-amyloid precursor protein in reactive astrocytes following neuronal damage. Neuron. 3:1989;275-285.
73. Simons M., Keller P., De Strooper B., Beyreuther K., Dotti C.G., Simons K. Cholesterol depletion inhibits the generation of beta-amyloid in hippocampal neurons. Proc Natl Acad Sci USA. 95:1998;6460-6464.
74. Skoog I., Hesse C., Fredman P., Andreasson L.-A., Palmertz B., Blennow K. Apolipoprotein E in cerebrospinal fluid in 85-year-olds. Relation to dementia, apolipoprotein E polymorphism, cerebral atrophy, and white-matter lesions. Arch Neurol. 54:1997;267-272.
75. Skoog I., Nilsson L., Palmertz B., Andreasson L.-A., Svanborg A. A population-based study of dementia in 85-year-olds. N Engl J Med. 328:1993;153-158.
76. Skoog I., Vanmechelen E., Andreasson L.A., et al. A population-based study of tau protein and ubiquitin in cerebrospinal fluid in 85-year-olds relation to severity of dementia and cerebral atrophy, but not to the apolipoprotein E4 allele . Neurodegeneration. 4:1995;433-442.
77. Skoog I., Wallin A., Fredman P., et al. A population-study on blood-brain barrier function in 85-year-olds. Relation to Alzheimer's disease and vascular dementia. Neurology. 50:1998;966-971.
78. Slooter A.J., Cruts M., Ott A., et al. The efffect of APOE on dementia is not through atherosclerosis the Rotterdam Study . Neurology. 53:1999;1593-1595.
79. Snowdon D.A., Greiner L.H., Mortimer J.A., Riley K.P., Greiner P.A., Markesbery W.R. Brain infarction and the clinical expression of Alzheimer disease. The Nun Study. JAMA. 277:1997;813-817.
80. Stephenson D.T., Rash K., Clemens J.A. Amyloid precursor protein accumulates in regions of neurodegeneration following focal cerebral ischemia in the rat. Brain Res. 593:1992;128-135.
81. Tanimukai H., Imaizumi K., Kudo T., et al. Alzheimer-associated presenilin-1 gene is induced in gerbil hippocampus after transient ischemia. Mol Brain Res. 54:1998;212-218.
82. Thomas N.J., Zhou Y., Buzek M., Selman W.R.S., Lust W.D., Kalaria R.N. APP and amylois beta in a guinea pig model of stroke. Soc Neurosci Abstr. 24:1998;1504. Abstract.
83. Tomimoto H., Wakita H., Akiguchi I., Nakamura S., Kimura J. Temporal profiles of accumulation of amyloid βA4 protein precursor in the gerbil after graded ischemic stress. J Cereb Blood Flow. 14:1994;565-573.
84. van Bockxmeer F.M., Mamotte C.D.S. Apolipoprotein E4 homozygosity in young men with coronary heart disease. Lancet. 340:1992;879-880.
85. Van der Cammen T.J.M., Vershoor C.J., Van Loon C.P.M., et al. Risk of left ventricular dysfunction in patients with probable Alzheimer's disease with APOE*4 allele. J Am Geriatr Soc. 46:1998;962-967.
86. Vaughan C.J., Delanty N. Neuroprotective properties of statins in cerebral ischemia and stroke. Stroke. 30:1999;1969-1973.
87. Vinters H.V. Cerebral amyloid angiopathy a critical review . Stroke. 18:1987;311-324.
88. Wang X.L., McCredie R.M., Wilcken D.E.L. Common DNA polymorphisms at the Lipoprotein Lipase gene. Association with severity of coronary artery disease and diabetes. Circulation. 93:1996;1339-1345.
89. Wilson P.W.F., Myers R.H., Larson M.G., Ordovas J.M., Wolf P.A., Schaefer E.J. Apolipoprotein E alleles, dyslipidemia, and coronary heart disease the Framingham offspring study . JAMA. 272:1994;1666-1671.
90. Zhan S.S., Beyreuther K., Schmitt H.P. Synaptophysin immunoreactivity of the cortical neuropil in vascular dementia of Binswanger type compared with the dementia of the Alzheimer type and nondemented controls. Dementia. 5:1994;79-87.